Literature DB >> 12446178

Arginase expression and modulation of IL-1beta-induced nitric oxide generation in rat and human islets of Langerhans.

P Stickings1, S K Mistry, J-L Boucher, S M Morris, J M Cunningham.   

Abstract

Proinflammatory cytokine induction of NO synthesis may contribute to the destruction of pancreatic beta cells leading to type 1 diabetes. The NO synthase substrate arginine can also be metabolized to ornithine and urea in a reaction catalyzed by cytosolic (AI) or mitochondrial (AII) isoforms of arginase. Recent evidence suggests that the rate of NO generation is dependent on the relative activities of NO synthase and arginase. The objectives of this study were (i). to identify the arginase isoforms expressed in rat and human islets of Langerhans and a rat beta cell line, RINm5F and (ii). to investigate the competition for arginine between NO synthase and arginase in IL-1beta-treated rat islets. Arginase activity was detected in rat islets (fresh tissue, 346 mU/mg protein; cultured, 587 mU/mg), cultured human islets (56 mU/mg), RINm5F cells (376 mU/mg), rat kidney (238 mU/mg), and rat liver (6119 mU/mg). Using Western blots, AI was shown to be the predominant isoform expressed in rat islets and in RINm5F cells while human islets expressed far more AII than AI. Rat islets were cultured in medium containing 1.14, 0.1, and 0.01 mM arginine and treated with IL-1beta and the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH). IL-1beta-induced NO generation was unaffected by ABH at 1.14 mM arginine, but significantly increased at 0.1 and 0.01 mM arginine. These findings suggest that the level of islet arginase activity can regulate the rate of induced NO generation and this may be relevant to the insulitis process leading to beta cell destruction in type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446178     DOI: 10.1016/s1089-8603(02)00122-2

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  6 in total

1.  CTL induction of tumoricidal nitric oxide production by intratumoral macrophages is critical for tumor elimination.

Authors:  Rodolfo D Vicetti Miguel; Thomas L Cherpes; Leah J Watson; Kyle C McKenna
Journal:  J Immunol       Date:  2010-11-01       Impact factor: 5.422

2.  Chronic oral administration of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) improves erectile function in aged rats.

Authors:  Robert Segal; Johanna L Hannan; Xiaopu Liu; Omer Kutlu; Arthur L Burnett; Hunter C Champion; Jae Hyung Kim; Jochen Steppan; Dan E Berkowitz; Trinity J Bivalacqua
Journal:  J Androl       Date:  2012-04-05

3.  Beneficial effects of L-arginine nitric oxide-producing pathway in rats treated with alloxan.

Authors:  Ana Vasilijevic; Biljana Buzadzic; Aleksandra Korac; Vesna Petrovic; Aleksandra Jankovic; Bato Korac
Journal:  J Physiol       Date:  2007-08-23       Impact factor: 5.182

4.  Ascorbate in aqueous humor augments nitric oxide production by macrophages.

Authors:  Kyle C McKenna; Kelly M Beatty; Rebecca C Scherder; Fuwang Li; Huanbo Liu; Alex F Chen; Arnab Ghosh; Dennis J Stuehr
Journal:  J Immunol       Date:  2012-12-12       Impact factor: 5.422

Review 5.  Development of novel arginase inhibitors for therapy of endothelial dysfunction.

Authors:  Jochen Steppan; Daniel Nyhan; Dan E Berkowitz
Journal:  Front Immunol       Date:  2013-09-17       Impact factor: 7.561

6.  Glucose-dependent partitioning of arginine to the urea cycle protects β-cells from inflammation.

Authors:  Accalia Fu; Juan Carlos Alvarez-Perez; Daina Avizonis; Tatsuya Kin; Scott B Ficarro; Dong Wook Choi; Esra Karakose; Mehmet G Badur; Lindsay Evans; Carolina Rosselot; Gaelle Bridon; Gregory H Bird; Hyuk-Soo Seo; Sirano Dhe-Paganon; Jurre J Kamphorst; Andrew F Stewart; A M James Shapiro; Jarrod A Marto; Loren D Walensky; Russell G Jones; Adolfo Garcia-Ocana; Nika N Danial
Journal:  Nat Metab       Date:  2020-05-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.